| 2026-04-26 |
AIRLMUM136516 |
RISING PHARMA HOLDINGS INC |
7540.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-04-26 |
AIRLMUM136517 |
RISING PHARMA HOLDINGS INC |
7504.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-04-09 |
AIRLMUM135538 |
RISING PHARMA HOLDINGS INC |
7997.0 kg |
291822.0
|
ASPIRIN DELAYED RELEASE TABLETS USP |
| 2026-03-13 |
AIRLMUM135042 |
RISING PHARMA HOLDINGS INC |
5842.0 kg |
291822.0
|
ASPIRIN DELAYED RELEASE TABLETS USP MG |
| 2026-03-01 |
AIRLMUM134445 |
RISING PHARMA HOLDINGS INC |
7548.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-03-01 |
AIRLMUM134443 |
RISING PHARMA HOLDINGS INC |
5913.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-03-01 |
AIRLMUM134444 |
RISING PHARMA HOLDINGS INC |
6028.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-02-15 |
AIRLMUM134252 |
RISING PHARMA HOLDINGS INC |
7535.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-02-11 |
AIRLMUM134200 |
RISING PHARMA HOLDINGS INC |
7393.0 kg |
291822.0
|
ACETAMINOPHEN TABLETS USP, ASPIRIN DELAYED RE |
| 2026-01-27 |
AIRLMUM133529 |
RISING PHARMA HOLDINGS INC |
8091.0 kg |
310510.0
|
ACETAMINOPHEN TABLETS USP MG |
| 2026-01-15 |
AIRLMUM133110 |
RISING PHARMA HOLDINGS INC |
8268.0 kg |
291822.0
|
ASPIRIN DELAYED RELEASE TABLETS USP MG |
| 2026-01-15 |
AIRLMUM133109 |
RISING PHARMA HOLDINGS INC |
8251.0 kg |
291822.0
|
ASPIRIN DELAYED RELEASE TABLETS USP MG |
| 2025-12-15 |
AIRLMUM132388 |
RISING PHARMA HOLDINGS INC |
7102.0 kg |
291822.0
|
ASPIRIN DELAYED RELEASE TABLETS USP MG |
| 2025-11-25 |
AIRLMUM131940 |
RISING PHARMA HOLDINGS INC |
8042.0 kg |
291822.0
|
ACERAMINOPHEN TABLETS USA USP, ASPIRIN DELAYE |
| 2025-08-20 |
OOLU276284416002 |
LIFESCIENCE LOGISTICS |
5240.0 kg |
300490
|
21 PACKAGES 698 CARTONS ON 21 PALLETS COVERING SHIPMENT OF PHARMACEUTICALS MEDICINES LIDOCAINE CREAM 5% (30GM) (LIDOCAINE 5% ANESTHITIC CREAM ANORECTED ) INVOICE NO-2025-26/0085 NDC NO-75834-333-30 PO NO :P.O.NO:-2025-01 DT.19.02.2025 HS CODE: 30049099 S/ |
| 2025-01-26 |
SWLVSWLAMD009399 |
M/S STRIVE PHARMACEUTICALS INC |
20368.0 kg |
310510
|
ACETAMINOPHEN AND DIPHENHYDRAMAINE HCL TABLETS |
| 2025-01-18 |
SWLVSWLAMD009337 |
SHREE HARI INTERNATIONAL LLC |
16876.0 kg |
310510
|
SENNA WITH DOCUSATE SODIUM TABLETS ACETAMINOPHEN,ASPIRIN AND CAFFEINE TABLETS DIPHENHYDRAMINE HCL 25MG TABLETS ASPIRIN DELAYED RELEASE TABS |
| 2025-01-18 |
SWLVSWLAMD009335 |
PRODOSE INC |
19095.0 kg |
291229
|
A.ACETAMINOPHEN TABS USP 500MG B.ACETAMINOPHEN TAB USP C.ACETAMINOPHEN & DIPHENHYDRAMINE CITRATE TABD.DIPHENHYDRAMINE HCL TABLETS USP 25MG-PINK |
| 2024-07-14 |
WZLTWINMUN005865 |
SHREE HARI INTERNATIONAL LLC |
18309.0 kg |
930400
|
ACTAMINOPHEN AND DIPHENHYDRAMAINE HCL TABLETSELAYED RELEASE TABS 81 MG |
| 2021-02-16 |
CMDUAMC1093072 |
SHRI HARI INTERNARIONAL LLC |
13165.0 kg |
300490
|
------------ TCLU5077390 DESCRIPTION---------TOTAL 589 PACKAGES (TOTAL FIVE HUNDRED EIGHTY NINE PACKAGES) PHENYLEPHRINE HYDROCHLORIDE TABLETS USP10MG GUAIFENSIN TABLETS USP400MG ACETAMINOPHEN,ASPRIN AND CAFFEINE TABLETS (S-53) NAPROXEN SODIUM TABLETS USP220MG (OVAL) HS CODE: 30049069,30049099 INV.NO.: 2020-21/0384, 2020-21/0385 DT: 31/12/2020 S.B.NO.: 7757023,7757957 DT 07/01/2021 FREIGHT PREPAID NET WT.:11749.55KGS -------------GENERIC DESCRIPTION-------------CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.EEA0143015 |